Planning a trip in the age of COVID-19 involves numerous considerations. One question that often arises is: “Can You Get Paxlovid Before Travel?” The answer, unfortunately, isn’t straightforward. With COVID-19 still a concern, especially for vulnerable individuals, understanding the availability and accessibility of Paxlovid for international travel is crucial.
Our recent plans to travel to Italy prompted us to delve into this very question. As individuals over 65, fully vaccinated, boosted, and diligent about mask-wearing, we wanted to explore every possible precaution. Could we pack Paxlovid “just in case”? Here’s what we discovered about obtaining Paxlovid for foreign travel, both before and during your trip.
What is Paxlovid?
Paxlovid (nirmatrelvir/ritonavir) is an FDA-approved antiviral medication designed to treat mild-to-moderate COVID-19 in individuals at high risk of progressing to severe illness. This includes older adults, people with chronic diseases, and those who are immunocompromised.
Clinical trial data from Pfizer indicated that Paxlovid reduced the risk of severe illness and death by 89% compared to a placebo. It’s also authorized under an Emergency Use Authorization (EUA) for adults and eligible pediatric patients (12 years and older, weighing at least 88 pounds) at high risk.
Pills of Paxlovid antiviral medication
Paxlovid is a key medication for high-risk individuals, but access can be a challenge.
While Paxlovid is a leading option, it’s not the only one. The CDC notes that Lagevrio is another antiviral treatment that can be taken at home. Remdesivir (Velkury) is also available but requires an IV infusion at a healthcare facility.
Who Should Consider Paxlovid?
Paxlovid is typically prescribed for individuals over 12 years old with weakened immune systems or underlying conditions such as asthma, cancer, liver disease, lung disease, heart disease, or obesity. People over 50 also fall into the high-risk category. Pfizer’s data suggests that those at the highest risk of adverse outcomes from COVID-19 benefit the most from the medication.
However, there are important caveats to consider:
- Paxlovid is not approved for pre- or post-exposure prevention.
- It is not authorized for patients requiring hospitalization due to severe COVID-19.
- Pediatric use is authorized under the EUA but not fully FDA-approved.
- It should not be used for more than five consecutive days.
Paxlovid and Foreign Travel: The Official Stance
The FDA’s Frequently Asked Questions (FAQ) section specifically addresses the question of obtaining Paxlovid for foreign travel:
QUESTION: I am traveling soon. May I receive Paxlovid under the EUA before travel in case I become sick with COVID-19?
ANSWER: Individuals being considered for Paxlovid treatment must meet the eligibility requirements under the EUA at the time of prescription. Providers must determine that patients have signs and symptoms consistent with mild-to-moderate COVID-19, assess risk for disease progression, assess renal and hepatic function, and review all medications taken by the patient to assess for potential drug-drug interactions and determine if other medicines that a patient may be taking require a dose adjustment, interruption and/or additional monitoring.
This response suggests that obtaining Paxlovid solely as a preventative measure before traveling is generally not permissible.
Why Carry Paxlovid While Traveling?
Despite the official stance, there are several compelling reasons why having Paxlovid on hand while traveling would be beneficial:
Increased Risk of Exposure
Travel inherently increases the risk of contracting viruses. Crowded airports, public transportation, restaurants, and tours expose travelers to more people and environments, making them more susceptible to infection.
Limited Access to Healthcare
Accessing healthcare and prescription medications in a foreign country can be challenging due to language barriers, unfamiliar healthcare systems, and varying medication availability.
Time Sensitivity
Paxlovid is most effective when taken within the first five days of symptom onset. Delays in accessing the medication can reduce its effectiveness.
Barriers to Paxlovid Access
Even without considering travel, several barriers limit Paxlovid access:
Lack of Awareness
A 2024 study in Health Affairs revealed that a significant portion of the population lacks awareness about Paxlovid. Many are misinformed about its effectiveness, potential side effects, and proper timing for use.
Cost
Since Pfizer transitioned to commercial sales in November 2023, the cost of Paxlovid has increased significantly. While programs like the U.S. Patient Assistance Program and Paxcess offer assistance, navigating these options can be complex.
Real-World Experiences: Paxlovid and Travel
Let’s examine some real-world experiences to understand the challenges of obtaining Paxlovid while traveling:
Travel Forums
Posts on travel forums like Rick Steves’ and Reddit highlight the difficulties travelers have faced in accessing Paxlovid abroad. Some were advised against trying to obtain it, while others found it impossible to get a prescription from local doctors.
Personal Accounts
One lucky traveler on Reddit was able to obtain a prescription from their doctor before leaving for Europe and successfully used Paxlovid when they tested positive during their trip. This highlights the potential benefits of having the medication on hand.
Insights from Medical Professionals
A physician friend in Italy reported that the typical approach for foreigners to get Paxlovid is to visit the Emergency Room of a public hospital, get tested, and, if positive, obtain a prescription from the National Health System.
Masks and awareness are key for safe travels during the pandemic.
Conclusion: Navigating Paxlovid Access for Travel
While carrying Paxlovid “just in case” seems ideal, it remains a challenge due to regulations and access barriers. The likelihood of obtaining a prescription solely for preventative purposes is slim.
The Department of Health and Human Services (DHHS) emphasizes that Paxlovid is “not a pre-treatment drug” and requires a current COVID-19 diagnosis for dispensation.
Paxlovid for Cruising
The issue of Paxlovid access is particularly relevant for cruises. Medical experts like Dr. Leana Wen suggest discussing the matter with your doctor, contacting the cruise line about their policies, and potentially seeking a second opinion if needed.
Ultimately, the decision to prescribe Paxlovid rests with healthcare providers who must adhere to guidelines and assess individual circumstances.
Resources
For more information, consider exploring these resources:
- Med Page Today: Why Aren’t More Doctors Prescribing Paxlovid?
- JAMA Medical News and Perspectives: Paxlovid Is Effective but Underused—Here’s What the Latest Research Says About Rebound and More
Staying informed and proactive is essential for safe and secure travel in the COVID-19 era.
